Klinische Monatsblätter für Augenheilkunde 1997-02-01

[Antazoline/tetryzoline eyedrops in comparison with levocabastine eyedrops in acute allergic conjunctivitis].

R Wertheimer, G Blessmann

Index: Klin. Monbl. Augenheilkd. 210(2) , 93-6, (1997)

Full Text: HTML

Abstract

Allergic conjunctivitis is one of the most frequent allergic diseases of the anterior eye segment.This multicentre, clinical trial was an investigation to compare the antiallergic efficacy, local tolerance and safety of Antazolin/Tetryzolin eye drops and Levocabastine eye drops. 69 patients were treated over a 2 weeks course of therapy. The subjective and objective ocular symptoms were documented over the treatment period.Both eye drops reduced subjective and objective ocular symptoms effective. The difference between the treatments (p = 0.0395) was the faster onset of action of Antazolin/Tetryzolin 30 minutes after administration of the first drop of trial medication.A fast and effective onset of action is of high clinical relevance. Therefore the benefits of using Antazolin/Tetryzolin eye drops was clearly outweigh.

Related Compounds

  • Antazoline
  • Antazoline Hydroc...

Related Articles:

Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study.

2010-01-01

[Eur. J. Ophthalmol. 20(5) , 811-8, (2010)]

Simultaneous determination of antazoline and naphazoline by the net analyte signal standard addition method and spectrophotometric technique.

2010-01-01

[J. AOAC Int. 93(6) , 1995-2001, (2010)]

Determination of antihistamines based on the formation of mixed aggregates with surfactants.

1998-05-01

[Analyst 123(5) , 1079-84, (1998)]

A rapid derivative spectrophotometric method for simultaneous determination of naphazoline and antazoline in eye drops.

2006-01-01

[Chem. Pharm. Bull. 54(1) , 119-22, (2006)]

Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation--a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study).

2012-01-01

[Trials 13 , 162, (2012)]

More Articles...